openPR Logo
Press release

Research report prospects the Ischemic Heart Disease Treatment Market

Research report prospects the Ischemic Heart Disease Treatment

Ischemic heart disease blocks blood supply to the heart. It is also known as coronary artery disease. Blood vessels get blocked or narrowed due to cholesterol deposition on the walls. This decreases nutrients and oxygen supply to heart muscles, which is important for appropriate functioning of the heart. This results in a part of the heart being rapidly run down of its blood supply and causes death of heart tissues. This leads to heart attack.

Heart is a pump that supplies oxygenated blood to the body or various organs. A less efficient heart directly disturbs the oxygen supply to the vital organs such as liver, kidney, and brain. This leads to death of tissues of these organs and eventual failure. Ischemic heart disease is one of the major causes of death in various countries. Major risk factors for ischemic heart disease are cholesterol levels, smoking, and diabetes mellitus. Moreover, persons with hypercholesterolemia have higher chance to develop the disease. Hypertension and stress are also major factors for development of ischemic heart disease. Genetic and hereditary factors are responsible for the disease.

Report Overview and TOC @ https://www.transparencymarketresearch.com/ischemic-heart-disease-treatment-market.html

Symptoms of ischemic heart disease is visible. These include acute chest pain related to unstable angina, angina pectoris, myocardial infraction, or acute coronary syndrome. Other symptoms include heart failure -struggle in breathing due to weakness of the heart muscle. Many people may have ischemic attacks without knowing it. People have ischemic attack without pain, known as silent ischemia. People may have heart attack without prior warning.

People who have angina may also have undiagnosed episode of silent ischemia. In addition, people with diabetes or people who had previous heart attacks are at high risk of developing silent ischemia. Ischemic heart disease can be prevented by avoiding stress, sedentary lifestyle, smoking, and fatty diet, as these are the major causes of ischemic heart diseases. Additionally, avoiding foods with high saturated fats in essential to decrease level of lipid in the blood stream and to stop arteriosclerosis. Regular exercise is also important to reduce the risk of ischemic heart disease. Hypertension and cholesterol should be under control with appropriate treatment.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30680

Ischemic heart disease is treated with various drugs such as aspirin, statins, calcium channel blockers, beta blockers, and organic nitrates. Increasing alcohol consumption & smoking and unhealthy lifestyle are the major factors fueling the growth of the ischemic heart disease treatment market. Rising obese and geriatric population also boosts market growth. However, high treatment cost and uncertainty in reimbursement are the major restraints of the ischemic heart disease treatment market.

For Specific and Customized requirements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=30680

The global ischemic heart disease treatment market has been segmented based on treatment, region, and end-user. In terms of treatment, the market has been classified into drugs and other treatments. The drugs segment has been sub-segmented based on drug class into NSAID, statins, calcium channel blockers, beta blockers, organic nitrates, and others. In terms of region, the global ischemic heart disease treatment market has been segmented into the Americas, EMEA, and Asia Pacific. Americas dominated the global market due to advanced lifestyle, consumption of fatty foods, and high obese & geriatric population. The market in Asia Pacific is expected to expand at a high growth rate, driven by rapidly developing economies such as China and India. Key market players operating in the global ischemic heart disease treatment market are Abbott Vascular, Terumo Corporation, Medtronic, and Boston Scientific Corporation, among others.

Pre Book full report@ https://www.transparencymarketresearch.com/ischemic-heart-disease-treatment-market.html?secure=NTIxNS41&type=PB

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Transparency Market Research

State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research report prospects the Ischemic Heart Disease Treatment Market here

News-ID: 853088 • Views: 302

More Releases from Transparency Market Research

Shipping Software Market to Reach Valuation of US$ 5 Bn by 2030: Transparency Ma …
Transparency Market Research delivers key insights on the global shipping software market. In terms of revenue, the global shipping software market is estimated to expand at a CAGR of ~9% during the forecast period of 2020-2030, owing to numerous factors regarding which TMR offers thorough insights and forecasts in its report on the global shipping software market. Get Report Details- https://www.transparencymarketresearch.com/shipping-software-market.html Increasing number of security breaches and cyber-attacks, and mandate to follow
Medium-voltage Switchgear Market Innovations , Competitive Analysis And Forecast
Transparency Market Research delivers key insights on the global medium-voltage switchgear market. In terms of revenue, the global medium-voltage switchgear market is estimated to expand at a CAGR of 5.5% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in its report on the global medium-voltage switchgear market. Report Details- https://www.transparencymarketresearch.com/medium-voltage-switchgear-market-2018-2026.html The global medium-voltage switchgear market is broadly affected by several factors, including the upgrading
IoT Device Management Market to Surpass Valuation of US$ 10.42 Bn by 2031: Trans …
Transparency Market Research delivers key insights on the global IoT device management market. In terms of revenue, the global IoT device management market is estimated to expand at a CAGR of 18.7 % during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global IoT device management market. Get Report Details- https://www.transparencymarketresearch.com/iot-device-management-market.html The global IoT device management market is broadly affected
Interactive Kiosk Market To Undertake Strapping Growth During 2022-2031
In recent years, the industry has grown rapidly due to developments in payment and security technology. It is predicted that several self-service kiosk manufacturers will seek to maximize the capabilities of these technologies and integrate them in their product offerings. Long lines in public locations such as malls, banks, and railway stations, as well as check-in desks at airports, can be avoided by the use of interactive kiosks. Get report

All 5 Releases


More Releases for Ischemic

Transient Ischemic Attack Market Forecast by 2025
Recent Transient Ischemic Attack market research and the current scenario as well as future market potential of "Global Transient Ischemic Attack Market Professional Survey Report 2020". The Transient Ischemic Attack Market comprehensively describes the market and prognosticates it to describe a highly illustrious growth during the anticipated years. The report offers an in-depth analysis of current and future Transient Ischemic Attack Market outlook across the globe. The report is projected
Global Ischemic Heart Disease Drugs Market Research Report 2017
Global Ischemic Heart Disease Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including AstraZeneca Bayer Actelion Bristol-Myers Squibb Boehringer Ingelheim ... On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Anti-dyslipidemic Drugs Calcium Channel Blockers Antithrombotic Agents ACE Inhibitors Vasodilators Beta-blockers On the basis on the end users/applications, this report focuses on the status and outlook for major
Ischemic Stroke - Pipeline Insight and Therapeutic Assessment 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Ischemic Stroke - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Ischemic Stroke. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265452 A comparative pipeline therapeutics assessment of Ischemic Stroke by development stage,
Ischemic Cerebral Stroke Market Outlook and Forecast up to 2024
Ischemic Cerebral Stroke Market: Overview Ischemic cerebral stroke occurs when blood vessels that supply blood to brain are blocked due to the formation of blood clots resulting in the corresponding loss of neurologic function. The symptoms of ischemic cerebral stroke complains include the abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level
North America Leads the Ischemic Cerebral Stroke Market Followed by Europe Major …
Ischemic Cerebral Stroke Market: Overview Ischemic cerebral stroke occurs when blood vessels that supply blood to brain are blocked due to the formation of blood clots resulting in the corresponding loss of neurologic function. The symptoms of ischemic cerebral stroke complains include the abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level
Acute Ischemic Stroke Diagnosis Market Size, Share and Growth 2021
According to the report “Acute Ischemic Stroke Diagnosis and Treatment Market “published by Market Data Forecast, the global market is projected to reach USD 2508 million by 2021, at a CAGR of 6.7% from 2016 to 2021. View Report at http://www.marketdataforecast.com/market-reports/global-acute-ischemic-stroke-diagnosis-market-265/ Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood supply to the brain. Rising prevalence of acute ischemia stroke cases